Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 2/20 | 0.56 |
| ▸ | CPA1 | P15085 | 2/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | FPR2 | P25090 | 4/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1012022 | 1.00 | MME (0.63) | MMENPSR1NAALAD2L3MBTL1ACE | |
| SCHEMBL1012023 | 1.00 | MME (0.63) | MMENPSR1NAALAD2L3MBTL1ACE | |
| Hydrochloric Acid SCHEMBL1262435 | 0.98 | MME (0.61) | MMENPSR1NAALAD2L3MBTL1ACE | |
| Ammonia Solution, Strong SCHEMBL10824808 | 0.98 | MME (0.61) | MMENPSR1NAALAD2L3MBTL1ACE | |
| Ammonia Solution, Strong SCHEMBL10824805 | 0.98 | MME (0.61) | MMENPSR1NAALAD2L3MBTL1ACE | |
| SCHEMBL6853867 | 0.89 | HPGDS (0.56) | MMEPOLBSMN1; SMN2 | |
| SCHEMBL26527726 | 0.86 | NAALAD2 (0.61) | MMENPSR1NAALAD2L3MBTL1FPR2 | |
| SCHEMBL8072837 | 0.86 | MME (0.60) | MMEACECPA1ACE2 | |
| SCHEMBL3829705 | 0.86 | FOLH1 (0.61) | MMENAALAD2L3MBTL1ACECPA1 | |
| SCHEMBL1498340 | 0.86 | MME (0.59) | MMENPSR1NAALAD2L3MBTL1ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7709235-B2 | 5-Substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and process for production of optically active N-carbamylamino acid or optically active amino acid | KANEKA CORPORATION (JP) | 2010-05-04 | — | — | US | claimed |
| US-20080261268-A1 | 5-Substituted Hydantoin Racemase, Dna Encoding the Same, Recombinant Dna, Transformed Cell, and Process for Production of Optically Active N-Carbamylamino Acid or Optically Active Amino Acid | KANEKA CORPORATION (JP) | 2008-10-23 | — | — | US | claimed |
| EP-1852510-A1 | 5-SUBSTITUTED HYDANTOIN RACEMASE, DNA ENCODING THE SAME, RECOMBINANT DNA, TRANSFORMED CELL, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE N-CARBAMYLAMINO ACID OR OPTICALLY ACTIVE AMINO ACID | Kaneka Corporation (JP) | 2007-11-07 | — | — | EP | claimed |
| CN-1376202-A | Stereostructure of decarbamylase and use thereof | KANEGAFUCHI CHEMICAL IND (JP) | 2002-10-23 | — | — | CN | claimed |
| EP-1209234-A1 | STEREOSTRUCTURE OF DECARBAMYLASE AND METHOD OF USING THE SAME | Kaneka Corporation (JP) | 2002-05-29 | — | — | EP | claimed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| CN-115772513-A | D-carbamyl hydrolase mutant, gene, expression vector and application thereof | 江南大学 | 2023-03-10 | — | — | CN | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| CN-115232130-A | APN and AKT double-target-point inhibitor and preparation method and application thereof | 山东大学 | 2022-10-25 | — | — | CN | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-111454933-B | D-carbamoyl hydrolase mutant and application thereof in synthesis of D-aromatic amino acid | 江南大学 | 2022-08-16 | — | — | CN | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-4418146-A | CBS 303.80 OR CBS 363.50 THERMOPHILIC, NON-SPORULATING STRAINS | BASF AKTIENGESELLSCHAFT (DE) | 1983-11-29 | — | — | US | disclosed |
| EP-0046186-A2 | Method of preparing D-N-carbamoyl-alpha-amino acids, and microorganisms therefor | BASF Aktiengesellschaft (DE) | 1982-02-24 | — | — | EP | disclosed |
| US-4312948-A | AGROBACTERIUM CULTURE | SNAMPROGETTI S.P.A. (IT) | 1982-01-26 | — | — | US | disclosed |
| US-4277404-A | INTERMEDIATES FOR TRANQUILIZERS | PFIZER INC. (US) | 1981-07-07 | — | — | US | disclosed |
| US-4267331-A | REDUCTIVE ALKYLATION OF A 5-PHENYL-2,3,4,4A,5,9B-HEXAHYDRO-1H-PYRIDO/4,3-B/INDOLE WITH A REDUCING AGENT AND A 2-HYDROXY-5- OR 6-PHENYLFURAN OR -PYRAN | PFIZER INC. (US) | 1981-05-12 | — | — | US | disclosed |
| US-4252812-A | TRANQUILIZERS | PFIZER INC. (US) | 1981-02-24 | — | — | US | disclosed |
| US-4237227-A | ENZYMATIC HYDROLYSIS OF A HYDANTOIN | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1980-12-02 | — | — | US | disclosed |
| US-4224329-A | TRANQUILIZERS | PFIZER INC. (US) | 1980-09-23 | — | — | US | disclosed |